Search Results for "Pharmac Cost Of Sativex In New Zealand"

14:29 EDT 28th May 2017 | BioPortfolio

Matching Channels

Marginal cost

TASH Biotechnology

Shanghai TASH Biotechnology Co.,Ltd. specializes in peptide development on the basis of high technology. TASH Biotechnology are focusing on custom peptide synthesis, and the research, development...


BAC’s CaptureSelect products are affinity ligands and affinity resins created by a proprietary technology based on Camelid-derived single domain antibody fragments for the purification of biop...


CombiCult® is an award winning, combinatorial screening technology that allows scientists to discover new and improved stem cell differentiation protocols. How Combicult® works A short o...

Latin America

Latin America encompasses the Caribbean, South America and Central America. These countries are important players in the biotechnology industry, not only as consumers, but as contributors. The env...

Matching News

New Zealand approval for Botox in DHB hospitals

New Zealand’s Pharmaceutical Management Agency PHARMAC has announce the approval of an agreement to…

Hunan Zhaotai Forms New Zealand JV for Cancer Drug Development

Hunan Zhaotai Medical Group has formed a cancer treatment JV with New Zealand's Malaghan Institute, which will conduct clinical trials on Zhaotai's CAR-T cancer drug portfolio in New Zealand. Zhaotai ...

AFT Pharmaceuticals (AFT) - Updates on several products

Edison Investment Research - Pharmaceutical & healthcare - AFT Pharmaceuticals: AFT Pharma recently made announcements affecting several of its marketed products. Importantly, the Australian Therapeut...

China's Premier Li arrives in New Zealand for talks

WELLINGTON, New Zealand (AP) — China's premier has arrived in New Zealand for high-level talks at a time that both countries are pushing to expand free trade.

Royal Society of New Zealand kicks off 150th celebrations

It’s a big day for the Royal Society of New Zealand Te Apārangi as it welcomes guests from all over the world to begin six months of celebrations around its 150th anniversary. I’ve been a...

New Zealand says US invokes immunity for embassy staffer

WELLINGTON, New Zealand (AP) — New Zealand authorities say they're unable to investigate an incident involving a U.S. Embassy staffer based in Wellington after the U.S. government elected to shi...

New Zealand's F&P Healthcare considers ways around proposed Trump tariffs on Mexico

WELLINGTON (Reuters) - New Zealand medical device firm Fisher & Payne Healthcare will consider switching factories making products bound for the United States from Mexico to New Zealand if U.S. Presid...

Zealand Pharma: CORRECTION: Zealand reports results for the first three months of 2017 (unaudited)

This is a correction of the announcement from 15:04 17.05.2017 CEST. Reason for the correction: Attachment of full report missing in previous release Company announcement - No. 15 / 2017 Zealand r...

Matching PubMed Articles

Patient response to use of tyrosine kinase inhibitors in lung cancer: a retrospective audit during funding changes.

The New Zealand Pharmaceutical Management Agency (PHARMAC) approved funding of erlotinib in October 2010 as second line therapy in all non-squamous non-small cell lung cancer after platinum-based chem...

High incidence of medulloblastoma in Māori and Pacific populations in New Zealand.

In New Zealand from 1995-2010, the incidence of medulloblastoma at ages 1-19 years was significantly higher in Māori (relative risk 2.0) and in Pacific peoples (RR 2.1) than in New Zealand Europeans.

Parental smoking during pregnancy: findings from the Growing Up in New Zealand cohort.

To investigate patterns of exposure to tobacco smoke in pregnancy among a representative sample of New Zealand women.

Traditional Chinese medicine practitioners in New Zealand: differences associated with being a practitioner in New Zealand compared to China.

While New Zealand has experienced an increase in the use of traditional Chinese medicine (TCM) based acupuncture, very little is known about the practitioners who provide this type of treatment modali...

Psychosocial enhancement of the Green Prescription for obesity recovery: a randomised controlled trial.

Kia Ākina is a low-cost obesity recovery network providing ongoing addiction-orientated psychosocial support. This study explored the impact of Kia Ākina when added to the Green Prescription, a key ...

Search Whole site using Google

Quick Search
Advertisement Advertisement